Project Details
Description
Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy (Narcolepsy Type 1)
| Status | Active |
|---|---|
| Effective start/end date | 11.12.2024 → 31.03.2027 |
Fields of science
- 302052 Neurology